Two Sigma Advisers »

Relmada Therapeutics shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 328k 4.14
2023-09-30 $493k 164k 3.00
2023-06-30 $604k 246k 2.46
2023-03-31 $808k 358k 2.26
2022-12-31 $1.1M 323k 3.49
2022-09-30 $796k 22k 37.02